Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Prostatic Hyperplasia × Dutasteride × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostatic Hyperplasia 1

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Urination 1 Transurethral Resection of Prostate 1 Magnetic Resonance Spectroscopy 1 Finasteride 1 Dutasteride 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡